rs144955489

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001127255.2(NLRP7):​c.3083C>T​(p.Thr1028Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,613,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1028A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

NLRP7
NM_001127255.2 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: -0.316

Publications

2 publications found
Variant links:
Genes affected
NLRP7 (HGNC:22947): (NLR family pyrin domain containing 7) This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
NCR1 (HGNC:6731): (natural cytotoxicity triggering receptor 1) Predicted to be involved in cellular defense response; regulation of natural killer cell mediated cytotoxicity; and signal transduction. Predicted to act upstream of or within defense response to virus and detection of virus. Predicted to be located in cell surface. Predicted to be part of SWI/SNF complex. Predicted to be active in plasma membrane. Biomarker of acquired immunodeficiency syndrome; anogenital venereal wart; hepatitis C; and lymphoproliferative syndrome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0550254).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127255.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP7
NM_001127255.2
MANE Select
c.3083C>Tp.Thr1028Met
missense
Exon 11 of 11NP_001120727.1Q8WX94-3
NLRP7
NM_001405531.1
c.3083C>Tp.Thr1028Met
missense
Exon 13 of 13NP_001392460.1Q8WX94-3
NLRP7
NM_139176.4
c.2999C>Tp.Thr1000Met
missense
Exon 11 of 11NP_631915.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP7
ENST00000592784.6
TSL:1 MANE Select
c.3083C>Tp.Thr1028Met
missense
Exon 11 of 11ENSP00000468706.1Q8WX94-3
NLRP7
ENST00000588756.5
TSL:1
c.3083C>Tp.Thr1028Met
missense
Exon 13 of 13ENSP00000467123.1Q8WX94-3
NLRP7
ENST00000340844.6
TSL:1
c.2912C>Tp.Thr971Met
missense
Exon 10 of 10ENSP00000339491.2Q8WX94-1

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152066
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000755
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000315
AC:
79
AN:
250984
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.000600
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000209
AC:
306
AN:
1461494
Hom.:
0
Cov.:
31
AF XY:
0.000219
AC XY:
159
AN XY:
727050
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33474
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.000393
AC:
21
AN:
53404
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5500
European-Non Finnish (NFE)
AF:
0.000236
AC:
262
AN:
1111974
Other (OTH)
AF:
0.000265
AC:
16
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41530
American (AMR)
AF:
0.0000655
AC:
1
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.000755
AC:
8
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000361
Hom.:
0
Bravo
AF:
0.000162
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000428
AC:
52
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Hydatidiform mole, recurrent, 1 (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.3
DANN
Uncertain
0.99
DEOGEN2
Benign
0.020
T
Eigen
Benign
-0.90
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.015
N
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.90
L
PhyloP100
-0.32
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.19
Sift
Benign
0.055
T
Sift4G
Uncertain
0.052
T
Polyphen
0.90
P
Vest4
0.096
MVP
0.35
MPC
0.26
ClinPred
0.029
T
GERP RS
-1.6
Varity_R
0.013
gMVP
0.14
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144955489; hg19: chr19-55435139; API